| Doctor's visit | price on request |
| Brain tumor removal | $23730.29 - $37752.74 |
Prof. Dr. Gülşah Bademci is a physician specialized in the field of brain, nerve, spine, and spinal cord surgery. She graduated as the fourth-ranked student from Ankara University Faculty of Medicine in 1993. She obtained her title as a brain and nerve surgeon from the Ankara University Faculty of Medicine Department of Brain and Nerve Surgery in 2001. In 2008, she became an associate professor at the Kırıkkale University Faculty of Medicine, and in 2021, she became a professor at the Yüksek İhtisas University Faculty of Medicine. She has contributed to numerous international publications, serving as a research and clinical fellow at the University of Arkansas Medical Sciences with Prof. Dr. M. Gazi Yaşargil, and as a research fellow at Yale University School of Medicine. She holds ECFMG America Board Step 1 and EANS European Board certificates. She speaks advanced-level English and has awards in tennis and swimming. She also pursues professional-level caricature art and medical illustration. In her 30-year career, she has performed numerous surgeries as a brain and nerve surgery specialist, particularly in spinal canal stenosis surgery, lumbar and cervical disc herniations, brain tumors, hydrocephalus surgery, and nerve compressions.
Read moreProf. Dr. Gülşah Bademci is a physician specialized in the field of brain, nerve, spine, and spinal cord surgery. She graduated as the fourth-ranked student from Ankara University Faculty of Medicine in 1993. She obtained her title as a brain and nerve surgeon from the Ankara University Faculty of Medicine Department of Brain and Nerve Surgery in 2001. In 2008, she became an associate professor at the Kırıkkale University Faculty of Medicine, and in 2021, she became a professor at the Yüksek İhtisas University Faculty of Medicine. She has contributed to numerous international publications, serving as a research and clinical fellow at the University of Arkansas Medical Sciences with Prof. Dr. M. Gazi Yaşargil, and as a research fellow at Yale University School of Medicine. She holds ECFMG America Board Step 1 and EANS European Board certificates. She speaks advanced-level English and has awards in tennis and swimming. She also pursues professional-level caricature art and medical illustration. In her 30-year career, she has performed numerous surgeries as a brain and nerve surgery specialist, particularly in spinal canal stenosis surgery, lumbar and cervical disc herniations, brain tumors, hydrocephalus surgery, and nerve compressions.
| Doctor's visit | price on request |
| Brain tumor removal | $23730.29 - $37752.74 |
Medical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms
Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.
Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.
All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.
The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.
Research areas of interest: Experimental protocols in the treatment of glioblastomas
- Prospective protocols in the treatment of brain metastases
- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors
- Intracranial meningiomas
- Cadaver lab dissection
Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).
In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).
Specialized training:
Prof. Pessina obtained his Degree in Medicine and Surgery in University of Insubria, Varese, where he also completed his Residency Program.
From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery
In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.
Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University
Additional information of interest:
Member of the Scientific Committee of the European Association of Neuroncology (EANO)
Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico
Read moreMedical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms
Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.
Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.
All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.
The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.
Research areas of interest: Experimental protocols in the treatment of glioblastomas
- Prospective protocols in the treatment of brain metastases
- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors
- Intracranial meningiomas
- Cadaver lab dissection
Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).
In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).
Specialized training:
Prof. Pessina obtained his Degree in Medicine and Surgery in University of Insubria, Varese, where he also completed his Residency Program.
From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery
In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.
Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University
Additional information of interest:
Member of the Scientific Committee of the European Association of Neuroncology (EANO)
Publications: https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico
Prof. Christian Winkler is a graduate of Medical University of Hanover and University of Lund, specializing in Parkinson’s disease treatment, atypical Parkinsonian syndrome, Huntington's disease, essential tremor, dystonia, ataxia, and unexplained movement disorders. He is a Chief Physician of the Neurological Clinic at Freiburg University Hospital and has been awarded multiple times for his research.
Read moreProf. Christian Winkler is a graduate of Medical University of Hanover and University of Lund, specializing in Parkinson’s disease treatment, atypical Parkinsonian syndrome, Huntington's disease, essential tremor, dystonia, ataxia, and unexplained movement disorders. He is a Chief Physician of the Neurological Clinic at Freiburg University Hospital and has been awarded multiple times for his research.
Dr. Nail Özdemir was born in Akhisar/Manisa on March 6, 1971. He graduated from Dokuz Eylül University Faculty of Medicine in 1994. He received his specialization in Neurosurgery from the Neurosurgery Department of Dokuz Eylül University Faculty of Medicine in 2002. From 2003 to 2010, he worked as a specialist at the Neurosurgery Clinic of Izmir Atatürk Education and Research Hospital, and from 2010 to 2019, he worked as a chief resident, associate professor, and lecturer at the Neurosurgery Clinic of Izmir Tepecik Education and Research Hospital. In 2013, while working at the Neurosurgery Clinic of Izmir Tepecik Education and Research Hospital, he became an associate professor. Since March 2019, he has been working as a freelance physician at his own private practice.
Read moreDr. Nail Özdemir was born in Akhisar/Manisa on March 6, 1971. He graduated from Dokuz Eylül University Faculty of Medicine in 1994. He received his specialization in Neurosurgery from the Neurosurgery Department of Dokuz Eylül University Faculty of Medicine in 2002. From 2003 to 2010, he worked as a specialist at the Neurosurgery Clinic of Izmir Atatürk Education and Research Hospital, and from 2010 to 2019, he worked as a chief resident, associate professor, and lecturer at the Neurosurgery Clinic of Izmir Tepecik Education and Research Hospital. In 2013, while working at the Neurosurgery Clinic of Izmir Tepecik Education and Research Hospital, he became an associate professor. Since March 2019, he has been working as a freelance physician at his own private practice.
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following: